Thus, LOI of IGF-II will cause higher levels of free IGF-II promoting increased Survivin, among other proteins, and stimulating a more aggressive breast cancer progression and a breast tumor that is less responsive to chemotherapy. The gene discussed is BIRC5; the disease is breast neoplasm.